搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
50 分钟
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In ...
GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...
1 小时
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...
The Global Legal Post
1 小时
GSK sues Moderna over Covid and RSV vaccines
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
STAT
2 小时
Pharmalittle: We’re reading about using Lilly obesity drug to reduce sick days, Sanofi ...
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
MedPage Today
3 小时
Serena Williams' Surgery; Moderna Sued Over COVID Vax; Brighter Nights and Mortality
Retired tennis star Serena Williams said she underwent a procedure to remove a benign branchial cyst "the size of a small ...
kffhealthnews
3 小时
Experts May Have Found A ‘Smoking Gun’ Underlying Long Covid
The Boston Globe reports on findings from researchers at Mass General Brigham who examined "reservoirs" of the covid virus that hide inside people after their acute infections have ended. Also in the ...
BioSpace
3 小时
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
大众网
4 小时
葛兰素史克(GSK.US)称RSV疫苗保护作用可持续三个季度
智通财经APP获悉,葛兰素史克 (GSK.US)周二表示,其呼吸道合胞病毒 (RSV)疫苗在接种后的三个季度都具有保护作用。经季节性因素调整后的数据显示,这种用于老年人的疫苗的三个季度累积有效性为62.9%。
The Pharma Letter
5 小时
GSK files lawsuit against Moderna
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...
Daily
6 小时
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files ...
London: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its ...
The Financial Express
6 小时
mRNA licensing agreements surge 800 percent in value as confidence grows beyond vaccines
GSK and CureVac restructured their 2020 collaboration into a new licensing agreement worth up to $1.57 billion in July 2024.
Axios on MSN
6 小时
GSK sues Moderna over mRNA vaccine technology
GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈